🚀 VC round data is live in beta, check it out!
BICO Group Valuation Multiples
Discover revenue and EBITDA valuation multiples for BICO Group and similar public comparables like Medinice, Humacyte, AVITA Medical, Suraksha Diagnostics and more.
BICO Group Overview
About BICO Group
BICO Group AB is a bio-convergence company. The company focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The Group consists of three reporting segments: Bioprinting, Life Science Solutions, and Lab Automation. Bioprinting consists of CELLINK, MatTek, Visikol, and Advanced BioMatrix. Life Science Solutions consists of CYTENA, DISPENDIX, Discover Echo, QInstruments, SCIENION, and Cellenion. Lab Automation consists of Biosero.
Founded
2000
HQ
Employees
726
Website
Financials (LTM)
EV
$165M
BICO Group Financials
BICO Group reported last 12-month revenue of $171M and EBITDA of $3M.
In the same LTM period, BICO Group generated $89M in gross profit, $3M in EBITDA, and had net loss of ($129M).
Revenue (LTM)
BICO Group P&L
In the most recent fiscal year, BICO Group reported revenue of $171M and EBITDA of $708K.
BICO Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $171M | XXX | $171M | XXX | XXX | XXX |
| Gross Profit | $89M | XXX | $85M | XXX | XXX | XXX |
| Gross Margin | 52% | XXX | 50% | XXX | XXX | XXX |
| EBITDA | $3M | XXX | $708K | XXX | XXX | XXX |
| EBITDA Margin | 2% | XXX | 0% | XXX | XXX | XXX |
| EBIT Margin | (45%) | XXX | (16%) | XXX | XXX | XXX |
| Net Profit | ($129M) | XXX | ($119M) | XXX | XXX | XXX |
| Net Margin | (75%) | XXX | (70%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
BICO Group Stock Performance
BICO Group has current market cap of $155M, and enterprise value of $165M.
Market Cap Evolution
BICO Group's stock price is $2.20.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $165M | $155M | 0.3% | XXX | XXX | XXX | $-1.68 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialBICO Group Valuation Multiples
BICO Group trades at 1.0x EV/Revenue multiple, and 56.1x EV/EBITDA.
EV / Revenue (LTM)
BICO Group Financial Valuation Multiples
As of April 20, 2026, BICO Group has market cap of $155M and EV of $165M.
Equity research analysts estimate BICO Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
BICO Group has a P/E ratio of (1.2x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $155M | XXX | $155M | XXX | XXX | XXX |
| EV (current) | $165M | XXX | $165M | XXX | XXX | XXX |
| EV/Revenue | 1.0x | XXX | 1.0x | XXX | XXX | XXX |
| EV/EBITDA | 56.1x | XXX | 232.9x | XXX | XXX | XXX |
| EV/EBIT | (2.1x) | XXX | (6.1x) | XXX | XXX | XXX |
| EV/Gross Profit | 1.8x | XXX | 1.9x | XXX | XXX | XXX |
| P/E | (1.2x) | XXX | (1.3x) | XXX | XXX | XXX |
| EV/FCF | (11.2x) | XXX | 34.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified BICO Group Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
BICO Group Margins & Growth Rates
BICO Group's revenue in the last 12 month grew by 4%.
BICO Group's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.2M for the same period.
BICO Group's rule of 40 is 11% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
BICO Group's rule of X is 20% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
BICO Group Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 4% | XXX | 2% | XXX | XXX | XXX |
| EBITDA Margin | 2% | XXX | 0% | XXX | XXX | XXX |
| EBITDA Growth | 246% | XXX | 1056% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 11% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 20% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 25% | XXX | 25% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 29% | XXX | 30% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 13% | XXX | 14% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 66% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
BICO Group Public Comps
See public comps and valuation multiples for other Medical Devices and Laboratory Services comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| BICO Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Medinice | XXX | XXX | XXX | XXX | XXX | XXX |
| Humacyte | XXX | XXX | XXX | XXX | XXX | XXX |
| AVITA Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Suraksha Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Atlantic International | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
BICO Group M&A Activity
BICO Group acquired XXX companies to date.
Last acquisition by BICO Group was on XXXXXXXX, XXXXX. BICO Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by BICO Group
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialBICO Group Investment Activity
BICO Group invested in XXX companies to date.
BICO Group made its latest investment on XXXXXXXX, XXXXX. BICO Group invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by BICO Group
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout BICO Group
| When was BICO Group founded? | BICO Group was founded in 2000. |
| Where is BICO Group headquartered? | BICO Group is headquartered in Sweden. |
| How many employees does BICO Group have? | As of today, BICO Group has over 726 employees. |
| Who is the CEO of BICO Group? | BICO Group's CEO is Maria Forss. |
| Is BICO Group publicly listed? | Yes, BICO Group is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of BICO Group? | BICO Group trades under BICO ticker. |
| When did BICO Group go public? | BICO Group went public in 2016. |
| Who are competitors of BICO Group? | BICO Group main competitors are Medinice, Humacyte, AVITA Medical, Suraksha Diagnostics. |
| What is the current market cap of BICO Group? | BICO Group's current market cap is $155M. |
| What is the current revenue of BICO Group? | BICO Group's last 12 months revenue is $171M. |
| What is the current revenue growth of BICO Group? | BICO Group revenue growth (NTM/LTM) is 4%. |
| What is the current EV/Revenue multiple of BICO Group? | Current revenue multiple of BICO Group is 1.0x. |
| Is BICO Group profitable? | Yes, BICO Group is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of BICO Group? | BICO Group's last 12 months EBITDA is $3M. |
| What is BICO Group's EBITDA margin? | BICO Group's last 12 months EBITDA margin is 2%. |
| What is the current EV/EBITDA multiple of BICO Group? | Current EBITDA multiple of BICO Group is 56.1x. |
| What is the current FCF of BICO Group? | BICO Group's last 12 months FCF is ($15M). |
| What is BICO Group's FCF margin? | BICO Group's last 12 months FCF margin is (9%). |
| What is the current EV/FCF multiple of BICO Group? | Current FCF multiple of BICO Group is (11.2x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.